We conclude that variants in FRMD3 contribute to the risk for nephropathy in AA with T2DM, an effect that was observed only after accounting for MYH9 (and less so APOL1) gene variants and evaluating a subset of AA cases likely enriched for T2DM-associated nephropathy. The gene discussed is APOL1; the disease is type 2 diabetes mellitus.